Broad cytokine and inflammatory signaling pathways (null)

Broad cytokine and inflammatory signaling pathways Overview

Broad cytokine and inflammatory signaling pathways represent a complex network of communication channels used by the immune system to coordinate responses to pathogens, tissue injury, and environmental stressors (StatPearls, 2023). These pathways are initiated when cytokines—small signaling proteins such as interleukins, interferons, and tumor necrosis factors—bind to specific high-affinity receptors on cell surfaces (National Cancer Institute, 2023). This binding triggers intracellular cascades, most notably the JAK-STAT, NF-kappaB, and MAPK pathways, which ultimately regulate the expression of genes involved in cell survival, proliferation, and the inflammatory response (Nature Reviews Molecular Cell Biology, 2021). While essential for host defense, chronic or excessive activation of these pathways is a primary driver of autoimmune diseases like rheumatoid arthritis and inflammatory bowel disease, as well as the systemic 'cytokine storms' observed in severe viral infections (PubMed, 2020). Pharmacological intervention typically targets specific nodes within these pathways, using monoclonal antibodies to sequester cytokines or small molecules to inhibit downstream kinases, thereby dampening the inflammatory fire without completely compromising the immune system (FDA, 2022). This entry is classified as 'incorrect' as a target because it describes a broad biological category rather than a single, specific molecular entity.

Mechanism of Action

Therapeutic modulation involves the neutralization of extracellular cytokines, blockade of their respective surface receptors, or the inhibition of intracellular signaling enzymes such as Janus kinases (JAKs) to prevent the transcription of pro-inflammatory genes.

Biological Functions

Safety Considerations

Interacting Drugs

Associated Biomarkers